Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (585)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
164
2025
3049
11.560
Why?
Antibodies, Monoclonal
26
2024
481
6.070
Why?
Hematopoietic Stem Cell Transplantation
28
2024
606
3.220
Why?
Antineoplastic Agents
18
2024
1222
3.160
Why?
Antineoplastic Combined Chemotherapy Protocols
42
2024
1031
3.160
Why?
Humans
219
2025
52336
2.230
Why?
Monoclonal Gammopathy of Undetermined Significance
11
2025
125
2.020
Why?
Thalidomide
24
2024
377
1.950
Why?
Neoplasm Recurrence, Local
15
2024
643
1.740
Why?
Immunotherapy, Adoptive
9
2024
167
1.710
Why?
Killer Cells, Natural
8
2024
116
1.680
Why?
Transplantation, Autologous
26
2024
488
1.680
Why?
Gene Expression Profiling
28
2025
1110
1.630
Why?
Interleukin-6
12
2023
278
1.600
Why?
Middle Aged
80
2025
13014
1.600
Why?
Neoplasm Proteins
13
2022
334
1.530
Why?
Hematologic Neoplasms
3
2022
106
1.520
Why?
Prognosis
48
2025
2094
1.490
Why?
Aged
80
2025
10109
1.440
Why?
Antigens, Neoplasm
6
2014
147
1.390
Why?
Clinical Trials as Topic
13
2022
468
1.370
Why?
Stem Cell Transplantation
10
2022
185
1.310
Why?
B-Cell Maturation Antigen
9
2025
98
1.290
Why?
Adult
60
2025
14139
1.250
Why?
Gene Expression Regulation, Neoplastic
20
2022
858
1.220
Why?
Combined Modality Therapy
19
2024
636
1.210
Why?
Chromosomes, Human, Pair 1
9
2023
96
1.200
Why?
Male
90
2025
26696
1.200
Why?
Female
92
2025
28105
1.180
Why?
Herpesvirus 8, Human
7
2021
98
1.170
Why?
Antibodies, Bispecific
6
2025
94
1.150
Why?
Translocation, Genetic
10
2022
265
1.140
Why?
Treatment Outcome
47
2024
5407
1.080
Why?
Boronic Acids
12
2013
183
1.070
Why?
Pyrazines
12
2013
190
1.070
Why?
Bone Marrow
18
2024
364
1.020
Why?
Proteasome Inhibitors
5
2024
105
1.010
Why?
Plasma Cells
12
2025
239
1.010
Why?
Immunotherapy
6
2024
244
0.960
Why?
Neoplasms, Second Primary
2
2024
77
0.940
Why?
Disease-Free Survival
24
2019
460
0.900
Why?
B-Lymphocytes
5
2024
185
0.880
Why?
Dexamethasone
14
2024
440
0.870
Why?
T-Lymphocytes, Cytotoxic
4
2014
66
0.860
Why?
Melphalan
9
2020
181
0.850
Why?
Cancer Vaccines
3
2010
78
0.830
Why?
Follow-Up Studies
26
2024
2268
0.820
Why?
Hyperhidrosis
1
2022
2
0.800
Why?
Sweat
1
2022
9
0.790
Why?
Survival Rate
24
2020
940
0.770
Why?
Lymphoma, B-Cell
3
2022
61
0.760
Why?
Drug Approval
1
2022
46
0.760
Why?
Positron-Emission Tomography
8
2025
303
0.730
Why?
Ehrlichia chaffeensis
1
2021
4
0.730
Why?
Patient Participation
1
2022
69
0.720
Why?
Ehrlichiosis
1
2021
14
0.720
Why?
T-Lymphocytes
8
2024
340
0.720
Why?
Cryosurgery
1
2021
36
0.710
Why?
Immunoglobulin Light Chains
3
2017
90
0.700
Why?
Disease Progression
17
2025
870
0.700
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
30
0.690
Why?
Embolization, Therapeutic
1
2021
88
0.670
Why?
Aged, 80 and over
22
2025
3391
0.670
Why?
Cell Proliferation
10
2023
1029
0.660
Why?
Neoplasm, Residual
9
2025
173
0.640
Why?
Chromosomal Instability
1
2019
16
0.640
Why?
Neoplasms, Plasma Cell
3
2024
37
0.620
Why?
Membrane Proteins
3
2006
340
0.620
Why?
Survival Analysis
18
2024
671
0.620
Why?
Adrenal Cortex Hormones
2
2023
114
0.610
Why?
Immunologic Factors
2
2018
117
0.600
Why?
Tumor Microenvironment
6
2024
255
0.580
Why?
Epigenesis, Genetic
4
2023
407
0.580
Why?
Chromosome Aberrations
12
2023
297
0.580
Why?
POEMS Syndrome
1
2018
34
0.570
Why?
Dendritic Cells
3
2014
136
0.570
Why?
Atrial Fibrillation
2
2022
200
0.560
Why?
Thyroid Neoplasms
1
2019
116
0.560
Why?
Polymorphism, Single Nucleotide
3
2024
506
0.550
Why?
Prealbumin
2
2014
22
0.550
Why?
Antibodies, Monoclonal, Humanized
6
2023
236
0.530
Why?
Receptors, Interleukin-6
2
2014
23
0.520
Why?
Cardiomyopathies
2
2014
123
0.490
Why?
Mutation
10
2022
1351
0.480
Why?
Risk Assessment
11
2025
1323
0.470
Why?
Osteolysis
4
2022
75
0.460
Why?
Immunotoxins
1
2014
6
0.450
Why?
Drug Resistance, Neoplasm
7
2024
327
0.440
Why?
Recurrence
13
2024
672
0.440
Why?
Cytotoxicity, Immunologic
2
2012
58
0.440
Why?
Risk Factors
20
2025
3872
0.440
Why?
Clonal Evolution
3
2020
58
0.430
Why?
Practice Guidelines as Topic
4
2023
487
0.430
Why?
Cyclophosphamide
5
2021
171
0.410
Why?
Health Status
1
2015
295
0.410
Why?
Amyloidosis
1
2014
85
0.410
Why?
Transplantation, Homologous
5
2017
150
0.410
Why?
Thrombocytopenia
3
2025
89
0.410
Why?
Diffusion Magnetic Resonance Imaging
3
2025
133
0.400
Why?
Fluorodeoxyglucose F18
6
2021
188
0.390
Why?
Remission Induction
13
2021
218
0.380
Why?
Genome-Wide Association Study
3
2024
186
0.380
Why?
Neutropenia
2
2023
115
0.380
Why?
Receptors, KIR
2
2008
12
0.370
Why?
Genetic Predisposition to Disease
3
2024
528
0.360
Why?
Bone Diseases
3
2021
95
0.360
Why?
Pyrimidines
2
2022
199
0.360
Why?
Dose-Response Relationship, Drug
8
2020
1377
0.360
Why?
Prospective Studies
9
2025
2428
0.360
Why?
Cytokines
3
2025
625
0.360
Why?
Lymph Nodes
5
2025
252
0.350
Why?
Azacitidine
1
2010
39
0.350
Why?
Benzamides
1
2010
50
0.350
Why?
Evolution, Molecular
2
2021
95
0.340
Why?
Histone Deacetylase Inhibitors
1
2010
58
0.340
Why?
C-Reactive Protein
6
2022
155
0.330
Why?
Prednisone
2
2021
102
0.330
Why?
Doxorubicin
6
2021
239
0.330
Why?
TOR Serine-Threonine Kinases
2
2020
82
0.320
Why?
Drug Administration Schedule
5
2015
372
0.320
Why?
Chromosome Deletion
5
2023
142
0.310
Why?
Metaphase
4
2016
46
0.310
Why?
Pelvis
2
2021
69
0.310
Why?
Quality of Life
1
2015
868
0.310
Why?
Vaccination
4
2022
297
0.310
Why?
Membrane Glycoproteins
2
2009
244
0.300
Why?
Paraproteinemias
3
2022
74
0.300
Why?
Disease Management
3
2025
188
0.300
Why?
Animals
15
2024
13523
0.290
Why?
Proportional Hazards Models
7
2024
443
0.290
Why?
Placebo Effect
2
2020
16
0.290
Why?
Fever
3
2025
112
0.290
Why?
Bone Neoplasms
4
2013
184
0.290
Why?
Young Adult
8
2025
4319
0.290
Why?
Adoptive Transfer
1
2007
29
0.280
Why?
Histocompatibility Antigens Class I
1
2007
48
0.280
Why?
Chromatin
3
2023
141
0.280
Why?
CD8-Positive T-Lymphocytes
3
2024
132
0.280
Why?
Cytogenetic Analysis
5
2023
80
0.270
Why?
Registries
4
2025
580
0.270
Why?
Boron Compounds
2
2024
19
0.270
Why?
DNA Methylation
4
2023
592
0.270
Why?
Chromans
2
2024
35
0.260
Why?
Vincristine
3
2021
88
0.260
Why?
Cell Membrane
1
2007
245
0.260
Why?
Mice, SCID
6
2013
182
0.260
Why?
Glycine
2
2024
75
0.260
Why?
Angiogenesis Inhibitors
5
2010
183
0.260
Why?
Down-Regulation
1
2007
347
0.260
Why?
In Situ Hybridization, Fluorescence
5
2023
263
0.250
Why?
Neoplasm Staging
6
2024
770
0.250
Why?
Consensus
3
2025
180
0.250
Why?
Cell Line, Tumor
9
2023
1436
0.250
Why?
Chromosomes, Human, Pair 17
2
2017
35
0.240
Why?
Vitamin E
2
2024
77
0.240
Why?
Transplantation Conditioning
5
2008
93
0.240
Why?
Case-Control Studies
6
2024
1201
0.240
Why?
Bone Resorption
2
2022
302
0.240
Why?
Mice
11
2024
5965
0.240
Why?
Infusions, Intravenous
3
2015
220
0.240
Why?
Flow Cytometry
4
2012
404
0.240
Why?
Connective Tissue Diseases
1
2025
20
0.230
Why?
Antibody Formation
1
2005
51
0.230
Why?
Immunoglobulins, Intravenous
1
2025
63
0.230
Why?
Time Factors
11
2021
2957
0.220
Why?
Polycomb Repressive Complex 2
2
2021
48
0.220
Why?
Autoantibodies
1
2025
121
0.220
Why?
Monocytes
2
2020
130
0.220
Why?
Gene Expression
2
2018
623
0.220
Why?
High-Throughput Nucleotide Sequencing
3
2022
179
0.210
Why?
Cell Cycle Proteins
2
2022
173
0.210
Why?
Blotting, Western
3
2015
596
0.210
Why?
Epstein-Barr Virus Infections
2
2020
33
0.210
Why?
Radiation-Protective Agents
1
2024
72
0.210
Why?
Proteasome Endopeptidase Complex
3
2011
141
0.210
Why?
Integrin beta Chains
1
2023
14
0.210
Why?
Signal Transduction
6
2021
1716
0.210
Why?
Integrins
1
2023
32
0.200
Why?
Ubiquitin-Protein Ligases
1
2024
140
0.200
Why?
Retrospective Studies
11
2025
6578
0.200
Why?
Double-Blind Method
2
2015
713
0.200
Why?
Cross-Sectional Studies
3
2023
1676
0.200
Why?
Sweating
1
2022
13
0.200
Why?
Hematopoietic Stem Cells
2
2022
188
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
81
0.190
Why?
Tumor Cells, Cultured
4
2013
456
0.190
Why?
DNA, Intergenic
1
2022
6
0.190
Why?
Kaplan-Meier Estimate
10
2016
484
0.190
Why?
Proteomics
3
2021
326
0.190
Why?
Immunoconjugates
1
2022
37
0.190
Why?
Receptors, Antigen, T-Cell
1
2022
55
0.190
Why?
Tumor Suppressor Protein p53
2
2017
224
0.190
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
United States Food and Drug Administration
1
2022
98
0.190
Why?
United States
4
2022
5182
0.190
Why?
Influenza, Human
1
2022
84
0.190
Why?
Mediastinum
1
2021
21
0.180
Why?
Chromosomes, Human, Pair 14
3
2020
75
0.180
Why?
Epigenomics
1
2021
75
0.180
Why?
Receptors, Glucocorticoid
2
2012
34
0.180
Why?
Apoptosis
5
2018
1127
0.180
Why?
Axilla
1
2021
92
0.180
Why?
Phosphatidylinositol 3-Kinases
2
2019
150
0.180
Why?
Ubiquitination
1
2021
57
0.180
Why?
Multiple Organ Failure
1
2021
47
0.180
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
91
0.180
Why?
Alleles
3
2021
277
0.180
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.180
Why?
Salvage Therapy
6
2013
136
0.180
Why?
Proto-Oncogene Proteins c-maf
2
2020
19
0.180
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.170
Why?
Adolescent
7
2025
6692
0.170
Why?
Rare Diseases
1
2020
47
0.170
Why?
Interferon-gamma
3
2014
179
0.170
Why?
Transcriptome
5
2025
367
0.170
Why?
Genes, Tumor Suppressor
2
2021
74
0.170
Why?
Radiopharmaceuticals
4
2021
205
0.170
Why?
Cell Cycle
1
2021
240
0.170
Why?
Longitudinal Studies
5
2024
741
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Interferon Type I
1
2020
28
0.170
Why?
Leukemia, Plasma Cell
1
2020
33
0.170
Why?
Myelodysplastic Syndromes
2
2013
86
0.170
Why?
Research Design
2
2020
354
0.160
Why?
Multivariate Analysis
8
2021
590
0.160
Why?
ROC Curve
2
2025
251
0.160
Why?
Genomics
4
2023
270
0.160
Why?
Gene Amplification
1
2019
58
0.160
Why?
Measles virus
1
2019
8
0.160
Why?
DNA
1
2023
550
0.160
Why?
Measles
1
2019
8
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Data Collection
1
2020
289
0.160
Why?
Immunohistochemistry
2
2015
985
0.160
Why?
Oncolytic Virotherapy
1
2019
21
0.160
Why?
Health Status Disparities
1
2022
216
0.160
Why?
Biopsy
5
2018
604
0.160
Why?
Patient Safety
1
2020
104
0.160
Why?
Sirolimus
1
2019
67
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
Why?
Cell Differentiation
6
2022
674
0.150
Why?
Precancerous Conditions
2
2010
85
0.150
Why?
Evidence-Based Medicine
2
2018
261
0.150
Why?
Syndrome
1
2019
247
0.150
Why?
Proto-Oncogene Proteins c-akt
1
2019
172
0.150
Why?
Healthcare Disparities
1
2022
299
0.150
Why?
MafB Transcription Factor
1
2018
9
0.150
Why?
Spleen
1
2019
173
0.150
Why?
Graft vs Host Disease
4
2007
88
0.150
Why?
Genomic Instability
2
2016
89
0.150
Why?
Immunomodulation
1
2018
37
0.150
Why?
Phosphotransferases
1
2018
17
0.150
Why?
Chemokines
1
2018
79
0.140
Why?
Plasma
1
2018
46
0.140
Why?
Myeloablative Agonists
2
2008
32
0.140
Why?
Hematopoietic Stem Cell Mobilization
2
2008
60
0.140
Why?
Osteoclasts
3
2022
428
0.140
Why?
Genes, Neoplasm
2
2015
31
0.140
Why?
Adipocytes
1
2018
130
0.140
Why?
Magnetic Resonance Imaging
5
2013
1543
0.140
Why?
Models, Biological
2
2018
743
0.140
Why?
Gene Dosage
2
2015
78
0.140
Why?
Gene Rearrangement
1
2018
75
0.140
Why?
Hexokinase
1
2017
16
0.140
Why?
Communication
1
2019
257
0.140
Why?
Heterozygote
2
2014
91
0.130
Why?
HLA-A Antigens
2
2007
11
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
Protein-Tyrosine Kinases
2
2018
89
0.130
Why?
Drug Therapy, Combination
1
2018
395
0.130
Why?
Oligonucleotide Array Sequence Analysis
5
2010
412
0.130
Why?
Gene Frequency
2
2013
99
0.130
Why?
Syndecan-1
4
2021
73
0.130
Why?
Critical Illness
1
2018
292
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
181
0.120
Why?
Lymphocyte Activation
2
2017
172
0.120
Why?
Tumor Burden
3
2020
136
0.120
Why?
Confidence Intervals
2
2014
158
0.120
Why?
Erythrocyte Indices
1
2015
7
0.120
Why?
Biomarkers, Pharmacological
2
2012
26
0.120
Why?
Immunity, Innate
1
2016
117
0.120
Why?
DNA Copy Number Variations
3
2022
117
0.120
Why?
Coculture Techniques
2
2013
145
0.120
Why?
Hemoglobins
2
2013
110
0.120
Why?
Cysteine-Rich Protein 61
1
2014
3
0.110
Why?
Hematologic Diseases
1
2014
21
0.110
Why?
Half-Life
1
2014
88
0.110
Why?
International Cooperation
1
2014
49
0.110
Why?
Fatigue
1
2015
125
0.110
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
236
0.110
Why?
Iron
1
2015
129
0.110
Why?
Area Under Curve
1
2014
181
0.110
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.110
Why?
Antibodies
2
2024
152
0.110
Why?
Reference Values
1
2014
313
0.110
Why?
Antineoplastic Agents, Alkylating
3
2008
77
0.110
Why?
Emotions
1
2015
174
0.110
Why?
Renal Insufficiency
2
2021
113
0.110
Why?
Severity of Illness Index
2
2014
1021
0.110
Why?
Neoplasms, Glandular and Epithelial
1
2014
41
0.110
Why?
Disease Models, Animal
2
2016
1484
0.110
Why?
Administration, Metronomic
1
2013
7
0.100
Why?
Cystatin M
2
2024
19
0.100
Why?
Inflammation Mediators
1
2014
117
0.100
Why?
Cisplatin
4
2013
285
0.100
Why?
Macaca mulatta
2
2024
92
0.100
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.100
Why?
beta Catenin
1
2013
103
0.100
Why?
Central Nervous System Neoplasms
1
2013
69
0.100
Why?
Oligopeptides
1
2013
93
0.100
Why?
Venous Thrombosis
2
2004
90
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.100
Why?
Leukemia
1
2013
67
0.100
Why?
Myelolipoma
1
2012
9
0.100
Why?
Edema
2
2025
65
0.100
Why?
Cell Survival
2
2020
602
0.100
Why?
Pain
1
2015
360
0.100
Why?
Mental Health
1
2015
240
0.100
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.100
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.100
Why?
Clone Cells
2
2023
77
0.100
Why?
Maintenance Chemotherapy
1
2012
51
0.100
Why?
Vascular Endothelial Growth Factor A
1
2013
186
0.100
Why?
Adaptor Proteins, Signal Transducing
2
2024
205
0.100
Why?
Models, Genetic
2
2016
172
0.100
Why?
Interleukin-2
1
2012
69
0.100
Why?
Mice, Inbred NOD
1
2012
92
0.090
Why?
Immunoenzyme Techniques
1
2012
137
0.090
Why?
Hemangioma
1
2013
84
0.090
Why?
Cell Movement
1
2013
277
0.090
Why?
Soft Tissue Neoplasms
1
2012
57
0.090
Why?
Immunoglobulin G
2
2025
195
0.090
Why?
Arkansas
5
2021
2028
0.090
Why?
Genotype
1
2013
569
0.090
Why?
Transcriptional Elongation Factors
2
2022
17
0.090
Why?
Transduction, Genetic
2
2014
44
0.090
Why?
Models, Statistical
2
2014
230
0.090
Why?
Chemokine CXCL13
2
2022
6
0.090
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
59
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
Immunoglobulin Idiotypes
1
2010
5
0.090
Why?
Hypersensitivity, Delayed
1
2010
18
0.090
Why?
CD40 Ligand
1
2010
15
0.090
Why?
Interleukin-4
1
2010
44
0.090
Why?
Secondary Prevention
1
2010
84
0.080
Why?
Up-Regulation
4
2018
462
0.080
Why?
HIV Seropositivity
1
2010
28
0.080
Why?
Eukaryotic Initiation Factor-2
1
2010
17
0.080
Why?
Immunity, Cellular
1
2010
64
0.080
Why?
Adjuvants, Immunologic
1
2010
52
0.080
Why?
Cell Line
2
2013
1045
0.080
Why?
Cells, Cultured
3
2013
1589
0.080
Why?
Etoposide
2
2007
72
0.080
Why?
Ovarian Neoplasms
1
2014
459
0.080
Why?
Transplantation, Heterologous
1
2009
79
0.080
Why?
Placenta
1
2011
154
0.080
Why?
Radiography
4
2012
470
0.080
Why?
Polymerase Chain Reaction
1
2010
460
0.080
Why?
Histones
2
2021
316
0.080
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.080
Why?
Hospitalization
2
2024
732
0.080
Why?
Transcription Factors
2
2023
574
0.070
Why?
Liver Neoplasms
1
2012
332
0.070
Why?
Lymphocyte Subsets
1
2008
14
0.070
Why?
Immunoglobulin lambda-Chains
1
2008
15
0.070
Why?
Granulocyte Colony-Stimulating Factor
1
2008
64
0.070
Why?
Haplotypes
1
2008
94
0.070
Why?
Bone and Bones
3
2021
494
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Gene Deletion
1
2009
276
0.070
Why?
Neoplastic Stem Cells
1
2009
93
0.070
Why?
Receptors, Immunologic
1
2008
37
0.070
Why?
Ligands
1
2008
207
0.070
Why?
Osteogenesis
1
2011
366
0.070
Why?
Twins
1
2007
33
0.070
Why?
Busulfan
1
2007
17
0.070
Why?
Diphosphonates
1
2008
92
0.070
Why?
Herpesviridae Infections
2
2019
57
0.070
Why?
Immunophenotyping
1
2007
117
0.070
Why?
Leukocytes, Mononuclear
1
2007
122
0.070
Why?
Caspases
2
2018
105
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Creatinine
1
2007
149
0.070
Why?
Skin Neoplasms
1
2012
500
0.070
Why?
Blood Proteins
1
2007
84
0.070
Why?
Antibodies, Neoplasm
1
2006
27
0.070
Why?
Graft vs Leukemia Effect
1
2006
2
0.060
Why?
Immunosuppressive Agents
1
2008
243
0.060
Why?
Chromosome Banding
1
2006
24
0.060
Why?
Plasmacytoma
1
2006
43
0.060
Why?
Cohort Studies
3
2020
1532
0.060
Why?
Amiloride
1
2005
7
0.060
Why?
HLA-A2 Antigen
1
2005
11
0.060
Why?
Bone Marrow Transplantation
2
2022
113
0.060
Why?
MicroRNAs
1
2010
387
0.060
Why?
Imaging, Three-Dimensional
2
2017
150
0.060
Why?
Decision Trees
1
2025
22
0.060
Why?
Sensitivity and Specificity
1
2007
879
0.060
Why?
Poly(ADP-ribose) Polymerases
2
2016
30
0.060
Why?
Child
3
2025
7157
0.060
Why?
Japan
1
2025
38
0.060
Why?
Predictive Value of Tests
3
2018
943
0.060
Why?
Tomography, X-Ray Computed
2
2023
1162
0.060
Why?
Autoantigens
1
2025
53
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Phthalimides
1
2024
3
0.060
Why?
Piperidones
1
2024
7
0.060
Why?
Enoxaparin
1
2004
30
0.060
Why?
Telomere
1
2024
38
0.060
Why?
Retreatment
1
2024
58
0.060
Why?
Morpholines
1
2024
65
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
NF-kappa B
2
2018
328
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
Cost of Illness
1
2024
120
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
57
0.050
Why?
Epidemiologic Methods
3
2008
46
0.050
Why?
Neoplasms
1
2014
1305
0.050
Why?
DNA, Neoplasm
2
2020
146
0.050
Why?
Gene Silencing
2
2016
119
0.050
Why?
Fibroblasts
1
2005
359
0.050
Why?
Cluster Analysis
3
2010
232
0.050
Why?
Cell Communication
1
2023
72
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
51
0.050
Why?
Geography
1
2022
66
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
34
0.050
Why?
Whole-Body Irradiation
1
2022
127
0.050
Why?
Guanine Nucleotide Exchange Factors
1
2022
18
0.050
Why?
Phenotype
1
2025
799
0.050
Why?
Inheritance Patterns
1
2022
22
0.050
Why?
Primary Cell Culture
1
2022
62
0.050
Why?
Patient Selection
1
2023
259
0.050
Why?
Quantitative Trait Loci
1
2022
50
0.050
Why?
Risk
2
2014
313
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2022
36
0.050
Why?
Oncogenes
1
2021
60
0.050
Why?
Anticoagulants
1
2004
267
0.050
Why?
Age of Onset
2
2013
109
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Child, Preschool
2
2020
4030
0.040
Why?
RANK Ligand
1
2022
187
0.040
Why?
Rabbits
2
2013
374
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Polymorphism, Genetic
1
2022
185
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
Base Sequence
1
2022
648
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Fibrosis
1
2021
197
0.040
Why?
Spatio-Temporal Analysis
1
2020
11
0.040
Why?
Repressor Proteins
1
2022
156
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
55
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Protein Kinase Inhibitors
1
2022
230
0.040
Why?
Single-Cell Analysis
1
2020
73
0.040
Why?
Genetic Loci
1
2020
49
0.040
Why?
Mice, Transgenic
1
2021
563
0.040
Why?
False Negative Reactions
1
2019
30
0.040
Why?
DNA Mutational Analysis
1
2020
180
0.040
Why?
Neoplasm Invasiveness
1
2020
278
0.040
Why?
Genetic Variation
1
2020
230
0.040
Why?
Incidence
2
2013
1059
0.040
Why?
Europe
1
2019
87
0.040
Why?
Herpesvirus 4, Human
1
2019
44
0.040
Why?
Communicable Disease Control
1
2019
38
0.040
Why?
Computational Biology
1
2020
211
0.040
Why?
beta 2-Microglobulin
2
2009
39
0.040
Why?
Genome, Viral
1
2019
83
0.040
Why?
DNA, Viral
1
2019
138
0.040
Why?
RNA, Messenger
2
2016
1142
0.040
Why?
Virus Diseases
1
2019
45
0.040
Why?
Fibrinogen
1
2018
34
0.040
Why?
Immunoglobulin A
1
2018
45
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
21
0.040
Why?
Bone Marrow Cells
2
2014
190
0.040
Why?
Platelet Count
2
2008
75
0.040
Why?
DNA-Binding Proteins
1
2021
429
0.040
Why?
Promoter Regions, Genetic
1
2020
474
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
Why?
Pathology, Molecular
1
2018
28
0.040
Why?
Oncogene Proteins, Fusion
1
2018
61
0.040
Why?
Data Interpretation, Statistical
2
2010
164
0.040
Why?
Databases, Factual
2
2013
706
0.030
Why?
Kidney Function Tests
1
2017
54
0.030
Why?
False Positive Reactions
1
2017
63
0.030
Why?
Glomerular Filtration Rate
1
2017
124
0.030
Why?
Lamins
1
2016
5
0.030
Why?
Cell Transformation, Neoplastic
1
2018
184
0.030
Why?
Chromosomes, Human, Pair 16
1
2016
18
0.030
Why?
Internationality
1
2017
43
0.030
Why?
Amino Acid Sequence
1
2018
591
0.030
Why?
Alkaline Phosphatase
1
2017
94
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
78
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
Proteolysis
1
2016
102
0.030
Why?
Enzyme Activation
1
2016
272
0.030
Why?
Glycolysis
1
2016
73
0.030
Why?
Chromosome Mapping
2
2006
155
0.030
Why?
Prevalence
1
2019
1007
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
97
0.030
Why?
Phosphorylation
1
2016
531
0.030
Why?
Kidney Diseases
1
2017
220
0.030
Why?
Asymptomatic Diseases
1
2014
38
0.030
Why?
Gene Fusion
1
2014
9
0.030
Why?
Interspersed Repetitive Sequences
1
2014
7
0.030
Why?
Karyotype
1
2014
19
0.030
Why?
Capsid
1
2014
2
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
7
0.030
Why?
Myocardium
1
2017
480
0.030
Why?
HIV-1
1
2014
59
0.030
Why?
Homozygote
1
2013
58
0.030
Why?
Cerebrospinal Fluid
1
2013
29
0.030
Why?
Genetic Vectors
1
2014
128
0.030
Why?
Diagnosis, Differential
1
2017
1044
0.030
Why?
Nicotinamide Mononucleotide
1
2013
4
0.030
Why?
Acrylamides
1
2013
8
0.030
Why?
Receptors, CXCR4
1
2013
29
0.030
Why?
Dependovirus
1
2014
103
0.030
Why?
Niacinamide
1
2013
24
0.030
Why?
Enzyme Induction
1
2013
77
0.030
Why?
NAD
1
2013
45
0.030
Why?
Amides
1
2013
37
0.030
Why?
Nitriles
1
2013
53
0.030
Why?
Sirtuin 1
1
2013
29
0.030
Why?
Chemokine CXCL12
1
2013
34
0.030
Why?
Gene Knockdown Techniques
1
2013
110
0.030
Why?
Transplantation Chimera
2
2003
16
0.020
Why?
RNA, Small Interfering
1
2013
218
0.020
Why?
Piperidines
1
2013
97
0.020
Why?
Infant
1
2020
3684
0.020
Why?
Lymphocyte Count
1
2011
20
0.020
Why?
Acute Disease
1
2013
374
0.020
Why?
Induction Chemotherapy
1
2012
64
0.020
Why?
Chemokine CXCL10
1
2011
20
0.020
Why?
HIV Infections
1
2016
388
0.020
Why?
Antibodies, Neutralizing
1
2011
79
0.020
Why?
Sex Factors
1
2013
727
0.020
Why?
Pharmacogenetics
1
2011
50
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
25
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
47
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
48
0.020
Why?
Enzyme Inhibitors
1
2013
374
0.020
Why?
Microarray Analysis
1
2010
69
0.020
Why?
International Classification of Diseases
1
2010
67
0.020
Why?
Argonaute Proteins
1
2010
12
0.020
Why?
RNA-Binding Proteins
1
2011
134
0.020
Why?
Oligonucleotides
1
2010
76
0.020
Why?
Polyploidy
1
2009
9
0.020
Why?
Bone Marrow Examination
1
2009
11
0.020
Why?
L-Lactate Dehydrogenase
1
2009
71
0.020
Why?
Neoplasm Metastasis
1
2009
240
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
38
0.020
Why?
Polyethylene Glycols
1
2008
89
0.020
Why?
Serum Albumin
1
2008
58
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
222
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
594
0.020
Why?
Age Distribution
1
2007
174
0.020
Why?
Recombinant Proteins
1
2008
491
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
53
0.020
Why?
Multigene Family
1
2006
50
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
87
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
203
0.020
Why?
Brain
1
2013
1323
0.010
Why?
Survivors
1
2006
118
0.010
Why?
Pregnancy
1
2011
2675
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Probability
1
2003
171
0.010
Why?
Administration, Oral
1
2003
451
0.010
Why?
Tissue Donors
1
2003
126
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Same Department Expand Description